Short Wave
Short Wave

Nov 18, 2026 · 15 min

A viral campaign accelerates a gene therapy for Sanfilippo syndrome

How a viral video gave a huge boost to new gene therapy

Eliza O’Neill’s story shows how family fundraising helped move a treatment toward approval while exposing the stakes of early access and nearly $4 million pricing.

3 key takeaways
  1. 1A viral video helped Eliza O’Neill’s family raise millions for research and clinical trials after her diagnosis.
  2. 2Researchers moved a modified-virus gene therapy from mouse studies through human trials and FDA approval as Fayuvie.
  3. 3Eliza’s progress underscores early treatment’s importance, while Fayuvie’s nearly $4 million cost raises access questions.

Don't miss

Eliza’s parents’ viral video raises millions for research while her condition continues to deteriorate and the clinical trial faces delays.

The brief

Eliza O’Neill was diagnosed as a young child with fatal Sanfilippo syndrome, a disease that progressively strips away speech, movement, and other abilities.

Researchers used a modified virus to deliver a healthy gene into the body and brain, but turning promising mouse results into human trials required money and coordination.

Eliza’s parents launched a video campaign that went viral and raised millions, helping sustain research as Eliza deteriorated and the trial faced delays.

The therapy eventually won FDA approval as Fayuvie, but its nearly $4 million price tag turns a scientific breakthrough into a question of access.

At 17, Eliza cannot speak but communicates with devices, attends school, and continues making progress—the first trial patient living with the treatment’s legacy.

Weekly email

State of the Pod, every Monday

The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.

Listen to the full episode and explore every guest, topic, and moment on PodLume.